INTRODUCTION

S
aponins are a vast class of natural products whose structural diversity includes a wide array of functional groups. Many compounds of this group are reported to have anti-inflammatory [1], anti-viral [2] , anti-tumor [3, 4] , hepatoprotective [5, 6] , anti-hyperlipidemic [5, 7] , anti-obesity [8, 9] , hypoglycemic [10] [11] [12] , antihypertensive [13] , immunomodulatory [14] [15] [16] , neuroprotective [17, 18] , anti-inflammatory [15, 19, 20] , anti-tumor [3, 21, 22] , anti-oxidant [18] , wound healing [23, 24] and anti-carcinogenic [20, [25] [26] [27] , anti-atherosclerositic [28] , cytotoxic and apoptotic activities [16, 22, [29] [30] [31] [32] and chemopreventive [20, 33, 34] effect.
Recently, saponins have been recognized as potent tumor inhibitors, and they have suddenly become one of the primary targets for new pharmacologically active anti-tumor molecules. Selective cytotoxic activity of oleanolic acid isolated from rhizomes of Astilbe chinensis towards the HeLa cancer cell line with a value of IC 50 = 6.49 µg/ mL was reported by H. X. Sun [35, 36] . Derivatives of oleanolic acid, that are formally derived from 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO), showed a range of interesting effects. In vitro studies have shown that CDDO induces cell differentiation, growth inhibition, and apoptosis in human leukemia [37, 38] , osteosarcoma [39] and breast cancer [40] cell lines. Further studies exhibited that the genes (IAP-2, BCL-2, C-MYC, VEGF, MMP-9) related with NF-κB (nuclear factor kappa B) were suppressed by CDDO. Another study showed that the cytotoxic action of CDDO and its derivatives in glioblastoma and neuroblastoma was through inhibition of NF-κB [41] . Two of synthetic oleanane derivatives, 2-cyano-3,12-dioxooleana-1,9(11)-dien28-oic acid (CDDO) and its methyl ester (CDDO-Me) are under evaluation in phase I clinical trials to test for their anti-cancer properties [19, 27, 35, 42] . B a r r i n g t o g e n o l C (o l e a n -1 2 -e n e -3β,16α,21β,22α,28β-pentol) (1), an oleanane-type triterpenoid is a prevalent pentacyclic triterpenoid which has been found in various plants in both aglycone and glycoside forms including Barringtonia racemose [43] , Aesculus pavia [44] , Eryngium yuccifolium [45] , Careya arborea [46] , Styrax japonica [47] , Styrax officinalis [48, 49] , Aesculus hippocastanum [50] and Antonia ovata [51] . Several barringtogenol C type triterpenoids have shown promising activities against A549 (human non-small cell lung tumor) [52] , PC-3 (human prostate) [52] , HL-60 (Human promyelocytic leukemia cells) [52] , PANC-1 (Human pancreatic carcinoma, epithelial-like cell line) [52] , MRC-5 (human fetal lung fibroblast) [52] , J-774 (murine monocyte/macrophage) [44] , WEHI-164 (murine fibrosarcoma) [44] and KB (human mouth epidermal carcinoma) [51] cell lines.
In the present study, we report the synthesis, characterization, and cytotoxicity of a new series of Barringtogenol C (1) derivatives against the cell lines of Human lung adenocarcinoma epithelial (A549), human cervix adenocarcinoma (HeLa), human colorectal adenocarcinoma (CaCo-2), human glioblastoma-astrocytoma (U-87 MG) and human breast adenocarcinoma (MCF-7).
cytotoxic activity against four cell lines (CaCo-2, HeLa, MCF-7, and U87MG) at below 100 µM concentration. Compounds 2c, 3a, 5d and 7 showed activity only on one cancer cell line (CaCo-2, U87MG, U87MG and MCF-7), respectively. Remaining derivatives are not active at 100 µM concentration (the highest dose tested). Within these series of compounds, 3a displayed considerable activity against U87MG cell line (IC 50 = 0.45 µM). While compound 1 is not active on these cell lines, the inhibitory activity of 3a was 26 times more potent than that of doxorubicin (IC 50 = 11.9 µM). Similarly, compounds 2a (5.28 µM), 2b (6.24 µM), 3b (6.08 µM), and 3c (4.25 µM) exhibited more potent activity than doxorubicin on the same cell lines. For the MCF-7 cell line, it was found that the most active compound was 2b (IC 50 = 5.19 µM), followed closely by 7 (IC 50 = 6.40 µM), were both more active than Doxorubicin. 2b and 7 also exhibited a better cytotoxic profile than compared with compound 1. For the CaCo-2 cell line, the most active compound was 2c (IC 50 = 14.3 µM) which exhibited a 1.5-fold increase in comparison with doxorubicin and compound 1. Moreover, 2a (IC 50 = 26.6 µM) and 2b (IC 50 = 18.8 µM), also showed moderate activity on these cells. While the inhibitory activity of 2b (IC 50 3c (IC 50 = 22.5 µM) showed moderate cytotoxic activity against HeLa cells. Also, for the A549 cell line, compound 2b (IC 50 = 34.7 µM) showed some cytotoxic activity despite compound 1 was not exhibited activity on this cells.
In addition, the cytotoxic effect of the compounds 2a-c, 3a-c, 4a-c, 5a-d, 6a,b and 7 were also tested on Vero cells and their effect on Vero cells growth is given in Table 1 . Only compounds 2a, 2b and 3c were found to be toxic to the growth of normal cells tested under in vitro conditions within all compounds examined.
Experimental
General Considerations
The reagents and solvents were purchased from Sigma-Aldrich, Merck and Alfa Aesar and were used as received. Column chromatography was performed on Silica gel 60 (0.063-0.200 mm,
Merck)
1 H NMR (400 MHz) and 13 C NMR (100 MHz or 150 MHz) spectra were acquired on a Varian AS 400 Mercury or Bruker Avance III HD Ascend 600 ULH spectrometer with CDCl 3 as solvent and tetramethylsilane (TMS) as internal standard. Chemical shifts (δ) were reported in units (ppm) by assigning TMS resonance in the 1 H spectrum as 0.00 ppm and CDCl 3 resonance in the 13 C spectrum as 77.0 ppm. All coupling constants (J values) were reported in Hertz (Hz). Elemental analyses were performed on a Perkin-Elmer PE 2400 elemental analyzer. FTIR spectra were recorded on a Perkin Elmer Spectrum 100 series. Mass spectra were acquired using a Bruker HCT Ultra Ion Trap Mass Spectrometer.
Plant Material
Pericarps of fruits of S. officinalis L. were collected in August 2011 in Kusadasi (Aydın, Turkey). A voucher specimen has been deposited in the herbarium of the Botanic Garden of Ege University. 13 13 
General Procedures for the Preparation of Compounds 3a-c
A solution of 1 (100.0 mg, 0.2 mmol), propionic anhydride (0.128 µl, 1 mmol), and DMAP (12.0 mg, 0.099 mmol) in dry pyridine (5 mL) was stirred at 120°C for 4 h. The reaction mixture was neutralized with 5% HCl (100 ml) and extracted with EtOAc. The organic layer was dried over anhydrous Na 2 SO 4 and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column with the solvent system Hexane: EtOAc (80:20) to yield 3a (30mg), 3b (20 mg) and 3c (20 mg 
General Procedures for the Preparation of Compounds 5a-d.
A solution of 1 (100.0 mg, 0.2 mmol), isobutyric anhydride (249 µl, 1,5 mmol), and DMAP (12.0 mg, 0.099 mmol) in dry pyridine (5 ml) was stirred at 120°C for 4 h. The reaction mixture was neutralized with 5% HCl (100 ml) and extracted with EtOAc. The organic layer was dried over anhydrous Na 2 SO 4 and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column with the solvent system Hexane: EtOAc (80:20) to yield 5a (25mg), 5b (15 mg,) 5c (15 mg) and 5d (15 mg 1H, m, H-19a 12-ene-3,16,21,22,28-pentol 1H, m, H-19a), 2.29 (1H, m, H-18), 1.91 (2H, m,  H-11), 1.87 (1H, m, H-2a), 1.83 (1H, m, H-15a ), 1.67 (1H, m, H-2b), 1.65 (1H, m, H-9), 1.64 (1H, m, H-1a ), 1.62 (1H, m, H-7a), 1.55 (1H, m, H-6a), 1.44 (1H, m,  H-6b), 1.41 (3H, s, H-27), 1.38 (1H, m, H-15b 
Olean-
General Procedures for the Preparation of Compounds 6a,b.
A solution of 1 (100.0 mg, 0.2 mmol), pivalic anhydride (304 µl, 1,5 mmol), and DMAP (12.0 mg, 0.099 mmol) in dry pyridine (5 mL) was stirred at 120°C for 4 h. The reaction mixture was neutralized with 5% HCl (100 ml) and extracted with EtOAc. The organic layer was dried over anhydrous Na 2 SO 4 and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column with the solvent system Hexane: EtOAc (80:20) to yield 6a (35mg) and 6b (20 mg (1H, m, H-15a), 1.66 (1H, m, H-2b), 1.65 (1H, m, H-9 ), 1.65 (1H, m, H-1a), 1.63 (1H, m, H-7a), 1.56 (1H, m,  H-6a), 1.44 (1H, m, H-6b), 1.40 (3H, s, H-27 12-ene-3,16,21,22,28-pentol 
Olean-
Cell Culture and in vitro Cytotoxicity Assay
Human lung adenocarcinoma epithelial (A549), human cervix adenocarcinoma (HeLa), human colorectal adenocarcinoma (CaCo-2), human glioblastoma-astrocytoma (U-87 MG), human breast adenocarcinoma (MCF-7) cells were used as cancer cell lines. Kidney epithelial cells from an African green monkey (Vero) were used as a noncancerous cell line. Cell lines were purchased from Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ, Germany). All the cells were maintained in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL of penicillin and 100 µg/mL of streptomycin (Biochrom AG, Berlin, Germany). The cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 .
Cytotoxicity of compounds were determined by following the general procedure based on cell viability using a modified MTT [3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide)] [53, 54] which measures the activity of mitochondrial reductase of viable cells colorimetrically. The assay is based on cleavage of MTT that forms formazan crystals. This cleavage appears in living cells with succinate-dehydrogenase. Adding dimethyl sulfoxide to wells helps formazan crystals to be dissolved. The optical density (OD) was measured at 570 nm (with a reference at 690 nm) by U.V. visible spectrophotometer (Thermo Scientific, USA) in triplicates. All cell lines were cultivated for 24 h in 96-well microplates with an initial concentration of 1x10 5 cells/ml. Then, the cultured cells were treated with different doses of 0-100 µM and incubated for 48 h at 37ºC. Doxorubicin, a chemotherapeutic agent, was used as a positive cytotoxic control drug. Percentages of surviving cells in each culture were determined after treat- Determination of IC 50 Inhibition of growth 50% (IC 50 ), which is the concentration of compounds causing 50% inhibition in cell growth compared to untreated controls, calculated by using OD values of controls and compounds doses as described previously. Cytotoxicity was expressed as an increase of the mean percentage of cytotoxicity relative to the unexposed control ± standard deviation (SD). Control values were set at 0% cytotoxicity. IC 50 was calculated by fitting the data to a sigmoidal curve and using a four parameters logistic model and presented as an average of three independent measurements. The IC 50 values were reported at 95% confidence interval and calculation was performed using GraphPad Prism software (San Diego, USA). The values of the blank wells were subtracted from each well of treated and control cells and inhibition of growth 50% was calculated in comparison with untreated controls.
CONCLUSIONS
In conclusion, 16 ester derivatives of barringtogenol C (1) have been synthesized and evaluated for the growth inhibition of various cancer cells such as CaCo-2, HeLa, MCF-7, A549 and U87MG cancer cell lines together with normal cells Vero. Several compounds have been found to have better or comparable anti-cancer potency in comparison with doxorubicin or barringtogenol C (1). Moreover, the cytotoxicity of the synthesized compounds appears to be selective on non-tumoral Vero cells, which tolerated substantially higher doses of these compounds than tumor cells. Among these, compounds 2a, 2b bearing an isopropylidene group at C21, C22 and C21, C28 showed an enhanced cytotoxic activity against the U87MG and CaCo-2 cell lines, respectively. However, the addition of isopropylidene moiety at C21, C22, C16 and C28, (2b) increased the activity of 1 on MCF-7, A549 and U87MG cell lines. While esterification of hydroxyl groups at C3, C21, C22 and C28 positions with propiyonic acid (3a) produced a considerable increase in the activity of 1 on U87MG cell lines, the addition of propanoate moiety at C3, C21 and C28 (3b) or C3, C22 and C28 (3c) positions led to an increase in cytotoxicity of U87MG and A549 cell lines. Regarding compound 4c, the results showed that substitution of C3, C22 and C28 hydroxyl groups with butanoic acid moiety increased activity against to U87MG and A549 cell lines. In case of compound 5d, isobutanoate groups at C3, C22 and C28 positions increased cytotoxicity against to U87MG cell lines. Nevertheless, the addition of benzoate moiety at C3, C21 and C28 positions (7) resulted in increased activity of 1 on U87MG cell lines.
